RxDoctor Payments Data

Douglas Wallace, MD

Family Medicine · Grove City, OHNPI 1063451144

Payments from drug & device makers

$1,211in general payments, 2019–2025

Across 99 payments — averaging $12.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$222
  • Novo Nordisk$188
  • Lilly USA, LLC$169
  • Boehringer Ingelheim$109
  • AstraZeneca$97
  • GSK$68
  • plus $358 from 9 others

What the payments were for

  • Food & beverage$1,19699%
  • Education$151%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,211 in reported general payments places this provider in the 65th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$91,288
Medicare patients
250
Services billed
1,814

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide164$246,872
EliquisApixaban165$158,506
XareltoRivaroxaban42$61,105
MounjaroTirzepatide39$53,151
JardianceEmpagliflozin47$49,262
Trelegy ElliptaFluticasone/Umeclidin/Vilanter52$49,075
TrulicityDulaglutide26$48,149
FarxigaDapagliflozin Propanediol38$35,214
NuedextaDextromethorphan Hbr/Quinidine18$20,119
Repatha SureclickEvolocumab13$20,112
Breo ElliptaFluticasone/Vilanterol29$11,009
Lantus SolostarInsulin Glargine,hum.Rec.Anlog115$10,175
ShingrixVaricella-Zoster Ge/As01b/Pf44$9,708
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr20$9,232
EntrestoSacubitril/Valsartan14$9,109

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$188$246,872164 claims
PfizerEliquis, Paxlovid$28$161,332198 claims
Lilly USA, LLCMounjaro, Trulicity$169$101,30065 claims
GSKTrelegy Ellipta, Breo Ellipta, Shingrix, Anoro Ellipta, Arnuity Ellipta$68$87,062164 claims
Johnson & JohnsonXarelto$60$61,10542 claims
Boehringer IngelheimJardiance, Stiolto Respimat$109$57,22762 claims
AstraZenecaFarxiga, Symbicort$97$41,35057 claims
Astellas Pharma US IncMyrbetriq$55$5,86413 claims
AbbVieSynthroid$28$3,98392 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$37$3,099339 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Grove City

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →